ThinkBio.Ai® transforms biological data into computable intelligence that accelerates discovery and improves clinical outcomes. Our platforms combine AI, biological expertise, and real-world evidence to help biopharma and healthcare organizations move faster, spend less, and make decisions grounded in biological truth.
At ThinkBio.Ai®, we envision a world where biology is transparent, computable, & clinically meaningful, where every insight drives action, every patient is understood, & every discovery brings us closer to care that is both personal & precise. Our mission is to make biology computable & clinically actionable. We harness advanced AI and real-world data to enable faster discoveries, reduce translational risk, & bring precision medicine to every patient, everywhere.
Our multidisciplinary team of 10+ MDs, 50+ PhD scientists, & over 100 AI & data engineers works as one integrated platform, translating complexity into clarity & discovery into care. With one of the industry’s largest biological data platforms & deep expertise across oncology, immunology, cardiology, & neurology, we partner with leading biopharma, biotech, and research institutions worldwide to accelerate discovery & improve translational outcomes.
ThinkBio.Ai® operates where AI meets biology & clinical decision-making, empowering global biopharma, biotech, & research leaders to advance discovery and precision medicine. With major industry partnerships & a second strategic collaboration underway, we are defining the computable biology category. Our proprietary biological knowledge graph, one of the largest of its kind, continues to evolve with every dataset, strengthening predictive insight, translational accuracy, & clinical impact.
ThinkBio.Ai® extends its impact through a trusted global network of consulting & technology partners. We provide access to advanced AI frameworks, biological knowledge assets, & translational intelligence that enable partners to deliver meaningful outcomes for their clients. Built on secure, compliant, & privacy-preserving infrastructure, our ecosystem ensures that innovation & clinical impact scale responsibly across the biopharma & healthcare landscape.
Pradeep Palazhi
Founder, President & CEODan Peterson
Co-founder & ChairmanSam Santhosh
Co-founder & Board MemberOur multidisciplinary team excels in computational biology, healthcare technology, and multi-omics analysis, enabling innovation in drug discovery and therapeutic targeting. We harness AI in spatial biology, imaging, and clinical informatics to optimize research workflows and improve healthcare delivery.
Our development team combines domain expertise with technical excellence to create scalable, compliant solutions for biopharma and healthcare. By streamlining workflows and automating processes, we address critical challenges to enhance efficiency in research and clinical operations.
A multidisciplinary group of AI engineers, data scientists, and computational biologists building the intelligence layer of ThinkBio.Ai®. They design and train models that integrate real-world evidence and curated datasets, enabling deeper biological understanding and predictive insights across drug discovery and development.
The core engineering group responsible for building scalable, secure, and high-performance infrastructure. They develop ML pipelines, data harmonization workflows, and analytics frameworks that power our research, clinical, and translational platforms, turning complex biological data into usable intelligence.
Where science, data, and AI unite to define the future of computable biology.
An integrated ecosystem of Seven AI platforms powered by proprietary biological knowledge graphs and foundation models. We unify research, clinical, and real-world data into a single, actionable system for biopharma innovation.
Founded in 2024, ThinkBio.Ai® has rapidly grown to 420+ employees across California, the UK, and India. Our multidisciplinary teams spanning AI engineering, biology, and clinical research deliver explainable, compliant, and scalable intelligence, safeguarded by 15 (in process) patents and 30 trademarks .
From target discovery and biomarker validation to clinical trials and post-market programs, our platform accelerates the journey from scientific insight to patient care, enabling faster, smarter, and more reliable translational outcomes.
Every deployment strengthens our secure, compliant platform. Each engagement enriches the biological knowledge graph, compounding predictive accuracy and partner value while powering the continuous evolution of computable biology worldwide.